Skip to content
DataLookout
Menu

NCT05849597

Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery

StatusCompleted
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Mar 1, 2022 to Jun 1, 2023 Show 6 more changesShow less
    • Eligibility criteria expanded, about 5 words
    • Trial completed
    • Final enrollment: 300 participants (planned 200)
    • Primary completion date changed from estimate of Feb 2025 to Feb 1, 2025
    • Study completion date changed from estimate of Jun 2025 to Jun 1, 2025
    • Site details revised
  2. Notable Primary completion date: Apr 2024 to Feb 2025
    • Study completion date: Dec 2024 to Jun 2025
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Occurrence of postoperative delirium
Timeframe: 5 days

Secondary (3)

MV duration
ICU length of stay
Hospital length of stay

Arms and interventions

DexmedetomidineExperimental

Evaluate the effects of dexmedetomidine for sedation of patients in the intensive care unit after open heart surgery

PropofolActive comparator

Compare the clinical outcomes of the experimental group with the standard of care, i.e. sedation with propofol

Drugs: Dexmedetomidine, Propofol

Sites

1 site in 1 country

  • Institute of Cardiovascular Diseases of VojvodinaKamenitz, Serbia